Figure 1.

Response to study treatment. (A) Summary of the maximum reduction in target lesion size in n = 52 patients with measurable disease and restaging scans. (B) Summary of the duration of response for the 17 patients who achieved a partial response by RECIST 1.1 criteria labeled by cancer type. The interval from date of enrollment to date of either progression or date of last disease assessment is displayed along with the first disease assessment to achieve partial response. Median duration of response was 4.8 months (maximum 17.2 months).